ulcerative colitis
Dashboard Shortens Therapy Gaps And Speeds Medication Delivery
Specialty pharmacists at Vanderbilt Health built user-friendly dashboards that have improved the speed of coverage ...
JUNE 15, 2025
Amneal Launches Mesalamine and Receives FDA Approval for Lenalidomide
Amneal Pharmaceuticals Inc. announced the launch of mesalamine 800-mg delayed-release tablets, an aminosalicylate ...
FEBRUARY 20, 2025
A Miss for FMT in Ulcerative Colitis, Additional Upadacitinib Benefits in Crohn’s
This month’s report looks at two distinct issues: fecal microbiota transplantation and upadacitinib.
SEPTEMBER 27, 2024
FDA Approves Guselkumab for UC
The FDA has approved guselkumab (Tremfya, Janssen) for patients with moderately to severely active ulcerative ...
SEPTEMBER 12, 2024
Data From Wearables Can Indicate Flares in Patients With IBD
Data collected by wearables, such as an Apple Watch, Fitbit or Oura Ring, can help uncover flares in people with UC ...
AUGUST 6, 2024
Subcutaneous Infliximab or Vedolizumab For Maintenance Therapy in IBD; Fast-Acting Upadacitinib in Crohn’s
In this month’s The Regueiro Report, I highlight two studies on medications to treat inflammatory bowel ...
JUNE 27, 2024
FDA Approves Risankizumab for Ulcerative Colitis
The FDA has approved risankizumab (Skyrizi, AbbVie) for patients with moderate to severe ulcerative colitis.
JUNE 27, 2024
Advanced Therapy Combinations Show Promise in Treating IBD
Therapeutic strategies employing a combination of advanced therapies are starting to reveal promising outcomes in ...
JANUARY 17, 2024
FDA Approves Omvoh for Adults With Moderately to Severely Active Ulcerative Colitis
The FDA approved mirikizumab-mrkz (Omvoh, Eli Lilly) infusion for the treatment of moderately to severely active ...
OCTOBER 27, 2023
FDA Approves Subcutaneous Vedolizumab for Moderate to Severe UC
The FDA has approved a subcutaneous version of Entyvio for maintenance therapy in adults with moderate to severe ...
OCTOBER 6, 2023
Racial Disparities Seen in Use of IBD Medical Therapy
Black patients with IBD are less likely to be treated with certain therapies than white IBD patients, according to ...
JANUARY 17, 2023
Opioid Use in Patients With IBD Continues Despite Risks
Which patients with inflammatory bowel disease are taking opioids? According to a new study, patients were more ...
DECEMBER 23, 2022
